Analysis Drawn from Medidata's PICAS Database Uncovers a Significant Increase in the Number of Distinct Procedures Impacting Both Trial Cost and Site and Patient Burden Drug Development Sponsors Can Use Data to Benchmark Against Organizational Practices and Help Optimize Protocol Design NEW YORK
Innovative pharmaceutical company leverages Medidata Clinical Cloud ® to accelerate the delivery of new therapies to market NEW YORK --(BUSINESS WIRE)--Nov. 1, 2017-- Medidata (NASDAQ:MDSO), the leading global provider of cloud-based technology and data analytics for clinical research, announced
Global Clinical Trial Technology Company Attracts Key Leader in Healthcare IT NEW YORK --(BUSINESS WIRE)-- Medidata Solutions (NASDAQ: MDSO), a leading global provider of SaaS-based clinical development solutions, today announced the election of Lee Shapiro to its board of directors.
Japanese CRO Builds New Services Around Leading Cloud-Based Clinical Research Platform to Enhance Trials, Extend Phase I-IV Services NEW YORK & TOKYO --(BUSINESS WIRE)-- ASKLEP Inc. , a leading Tokyo -based provider of clinical research services, has joined the Medidata Solutions (NASDAQ: MDSO)
Medidata's Cutting-Edge Technology Platform Will Enable Top-20 Global Pharma to Conduct Faster, More Accurate and More Cost-Effective Clinical Trials Selection of Medidata Underscores Boehringer Ingelheim's Commitment to Deploy Best-in-Class Technology to Power Groundbreaking Medical Advances NEW
Medidata's Technology Platform and Data Analytics Maximize Value of Clinical Data, Enhance Trial Design and Execution, and Enable More Agility in Drug Development NEW YORK --(BUSINESS WIRE)-- Medidata (NASDAQ:MDSO), the leading global provider of cloud-based solutions for clinical research in life